A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF
Ling-Shiang Chuang(Icahn School of Medicine at Mount Sinai), Vincent Plagnol(University College London), Subra Kugathasan(Children's Healthcare of Atlanta), James George(Icahn School of Medicine at Mount Sinai), Itsik Pe’er(Columbia University), Todd Lencz(Feinstein Institute for Medical Research), Ken Hui(Yale University), María T. Abreu(Icahn School of Medicine at Mount Sinai), Talin Haritunians(Cedars-Sinai Medical Center), Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Joanne M. Stempak(Mount Sinai Hospital), Adeeb Rahman(Immunai (United States)), B.M. Bowen(Yale University), Kent D. Taylor(Cedars-Sinai Medical Center), Wei Zhang(Shihezi University), Jerome I. Rotter(Harbor–UCLA Medical Center), Arthur Mortha(University of Toronto), Seymour Katz(New York University), Alexander Gusev(Dana-Farber Cancer Institute), Yashoda Sharma(American Society of Law, Medicine and Ethics), Gil Atzmon(Oranim Academic College of Education), Jacob L. McCauley(University of Cambridge), L. Philip Schumm(Chicago Department of Public Health), Stephan R. Targan(Cedars-Sinai Medical Center), Nir Barzilai(Albert Einstein College of Medicine), Adam S. Cheifetz(Beth Israel Deaconess Medical Center), Elena Schiff(University College London), Sok Meng Evelyn Ng(Yale University), Tramy Luong(Icahn School of Medicine at Mount Sinai), Lisa W. Datta(Johns Hopkins University), Jody‐Ann Facey(Icahn School of Medicine at Mount Sinai), Kaida Ning(Yale University), Manuel A. Rivas(Stanford University), Hongyu Zhao(Yale University), Marla Dubinsky(Cedars-Sinai Medical Center), Sacha Gnjatic(Tisch Hospital), Clara Abraham(Yale University), Nicole Villaverde(Icahn School of Medicine at Mount Sinai), Seth Lipka(University of South Florida), Nikolas Pontikos(Moorfields Eye Hospital), Ariel Darvasi(Hebrew University of Jerusalem), Adam P. Levine, Håkon Håkonarson(Children's Hospital of Philadelphia), Heriberto Fernandez-Hernandez(Icahn School of Medicine at Mount Sinai), Romain Remark(Memorial Sloan Kettering Cancer Center), Robert J. Desnick(Icahn School of Medicine at Mount Sinai), Dalin Li(Cedars-Sinai Medical Center), Peter Legnani(Icahn School of Medicine at Mount Sinai), Nai-Yun Hsu(Icahn School of Medicine at Mount Sinai), Ellen Scherl(NewYork–Presbyterian Hospital)
Cited by 67
Related Papers
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k